Phase II trial of combination chemotherapy consisting of pegylated liposomal doxorubicin and carboplatin in patients with recurrent ovarian cancer

Update Il y a 4 ans
Reference: JPRN-UMIN000002691

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract


Inclusion criteria

  • Epithelial ovarian cancer, primary fallopian tube cancer, or peritoneal cancer in late relapse (>6 months) after 1st-line chemotherapy

Links